194 related articles for article (PubMed ID: 9499378)
1. Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion.
Stahn R; Schäfer H; Kernchen F; Schreiber J
Glycobiology; 1998 Apr; 8(4):311-19. PubMed ID: 9499378
[TBL] [Abstract][Full Text] [Related]
2. Selectin ligands on human melanoma cells.
Miller N; Vile RG; Hart IR
Glycoconj J; 1996 Feb; 13(1):33-43. PubMed ID: 8785485
[TBL] [Abstract][Full Text] [Related]
3. In vivo ligand specificity of E-selectin binding to multivalent sialyl Lewisx N-linked oligosaccharides.
Thomas VH; Yang Y; Rice KG
J Biol Chem; 1999 Jul; 274(27):19035-40. PubMed ID: 10383404
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
Maaheimo H; Renkonen R; Turunen JP; Penttilä L; Renkonen O
Eur J Biochem; 1995 Dec; 234(2):616-25. PubMed ID: 8536711
[TBL] [Abstract][Full Text] [Related]
5. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion.
Turunen JP; Majuri ML; Seppo A; Tiisala S; Paavonen T; Miyasaka M; Lemström K; Penttilä L; Renkonen O; Renkonen R
J Exp Med; 1995 Oct; 182(4):1133-41. PubMed ID: 7561686
[TBL] [Abstract][Full Text] [Related]
6. Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells.
Welply JK; Abbas SZ; Scudder P; Keene JL; Broschat K; Casnocha S; Gorka C; Steininger C; Howard SC; Schmuke JJ
Glycobiology; 1994 Jun; 4(3):259-65. PubMed ID: 7524825
[TBL] [Abstract][Full Text] [Related]
7. Studies on selectin-carbohydrate interactions.
Jacob GS; Welply JK; Scudder PR; Kirmaier C; Abbas SZ; Howard SC; Keene JL; Schmuke JJ; Broschat K; Steininger C
Adv Exp Med Biol; 1995; 376():283-90. PubMed ID: 8597260
[TBL] [Abstract][Full Text] [Related]
8. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the dynamic strength of the sialyl Lewis X--selectin interaction.
Zhang X; Bogorin DF; Moy VT
Chemphyschem; 2004 Feb; 5(2):175-82. PubMed ID: 15038277
[TBL] [Abstract][Full Text] [Related]
10. Higher-affinity oligosaccharide ligands for E-selectin.
Nelson RM; Dolich S; Aruffo A; Cecconi O; Bevilacqua MP
J Clin Invest; 1993 Mar; 91(3):1157-66. PubMed ID: 7680663
[TBL] [Abstract][Full Text] [Related]
11. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.
Takada A; Ohmori K; Takahashi N; Tsuyuoka K; Yago A; Zenita K; Hasegawa A; Kannagi R
Biochem Biophys Res Commun; 1991 Sep; 179(2):713-9. PubMed ID: 1716885
[TBL] [Abstract][Full Text] [Related]
12. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity.
Revelle BM; Scott D; Beck PJ
J Biol Chem; 1996 Jul; 271(27):16160-70. PubMed ID: 8663282
[TBL] [Abstract][Full Text] [Related]
13. L-selectin ligands in rat high endothelium: multivalent sialyl Lewis x glycans are high-affinity inhibitors of lymphocyte adhesion.
Toppila S; Lauronen J; Mattila P; Turunen JP; Penttilä L; Paavonen T; Renkonen O; Renkonen R
Eur J Immunol; 1997 Jun; 27(6):1360-5. PubMed ID: 9209485
[TBL] [Abstract][Full Text] [Related]
14. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.
Zeisig R; Stahn R; Wenzel K; Behrens D; Fichtner I
Biochim Biophys Acta; 2004 Jan; 1660(1-2):31-40. PubMed ID: 14757218
[TBL] [Abstract][Full Text] [Related]
15. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.
Phillips ML; Nudelman E; Gaeta FC; Perez M; Singhal AK; Hakomori S; Paulson JC
Science; 1990 Nov; 250(4984):1130-2. PubMed ID: 1701274
[TBL] [Abstract][Full Text] [Related]
16. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.
Munro JM; Lo SK; Corless C; Robertson MJ; Lee NC; Barnhill RL; Weinberg DS; Bevilacqua MP
Am J Pathol; 1992 Dec; 141(6):1397-408. PubMed ID: 1281620
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium.
Seppo A; Turunen JP; Penttilä L; Keane A; Renkonen O; Renkonen R
Glycobiology; 1996 Jan; 6(1):65-71. PubMed ID: 8991511
[TBL] [Abstract][Full Text] [Related]
18. Ligand interactions with E-selectin. Identification of a new binding site for recognition of N-acyl aromatic glucosamine substituents of sialyl Lewis X.
Ramphal JY; Hiroshige M; Lou B; Gaudino JJ; Hayashi M; Chen SM; Chiang LC; Gaeta FC; DeFrees SA
J Med Chem; 1996 Mar; 39(7):1357-60. PubMed ID: 8691465
[TBL] [Abstract][Full Text] [Related]
19. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells.
Walz G; Aruffo A; Kolanus W; Bevilacqua M; Seed B
Science; 1990 Nov; 250(4984):1132-5. PubMed ID: 1701275
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Functional Characterization of Novel Sialyl LewisX Mimic-Decorated Liposomes for E-selectin-Mediated Targeting to Inflamed Endothelial Cells.
Chantarasrivong C; Ueki A; Ohyama R; Unga J; Nakamura S; Nakanishi I; Higuchi Y; Kawakami S; Ando H; Imamura A; Ishida H; Yamashita F; Kiso M; Hashida M
Mol Pharm; 2017 May; 14(5):1528-1537. PubMed ID: 28191842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
